These findings are supported by recent oncoproteomics studies in which ATP5B and some other subunits of F1F0-ATP synthase were found to be down-regulated in several kinds of tumor cell lines and tissues such as colorectal cancer, and to be associated with tumor drug-resistance29 and oncogenic pathway activation33. Here, ATP5F1B is linked to neoplasm.